Genometrix Incorporated provides cost-effective, high-throughput genomic services and information. Genometrix believes that applied genomics the practical use of genetic research and information is the key toreducing the risks, costs and lead-times of drug discovery and to the development of personalized medicine. Genometrix's genotyping, gene expression and bioinformatics services will help to advance the frontier of personalized medicine by combining highly innovative technology with efficient operations. The firm filed for an IPO but then withdrew in Febuary 2001
